Mohamad O. Khawandanah

Hematology
800 NE 10th St
Oklahoma City, OK 73104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.

Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.

Journal: Blood
Published: March 18, 2026

Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy in patients with myelofibrosis.

Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy in patients with myelofibrosis.

Journal: Blood advances
Published: November 06, 2025

Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy for patients with myelofibrosis.

Phase 1b study of ABBV-744, a novel, selective BET inhibitor, as monotherapy for patients with myelofibrosis.

Journal: Blood advances
Published: November 06, 2025

Ziftomenib in Relapsed or Refractory NPM1-Mutated AML.

Ziftomenib in Relapsed or Refractory NPM1-Mutated AML.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 25, 2025

The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysis.

The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysis.

Journal: Leukemia research
Published: August 02, 2025

Cardiovascular disease-related mortality trends among adults with multiple myeloma in the United States from 1999 to 2023.

Cardiovascular disease-related mortality trends among adults with multiple myeloma in the United States from 1999 to 2023.

Journal: Leukemia research
Published: February 06, 2025

Diagnostic Odyssey: Primary CNS Lymphoma (Lymphoma Cerebri) Presenting as Rapidly Progressive Dementia.

Diagnostic Odyssey: Primary CNS Lymphoma (Lymphoma Cerebri) Presenting as Rapidly Progressive Dementia.

Journal: Case reports in hematology
Published: December 04, 2024

Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survival.

Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survival.

Journal: Cancer medicine
Published: June 19, 2023

Disseminated histoplasmosis after alemtuzumab.

Disseminated histoplasmosis after alemtuzumab.

Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: June 06, 2023

Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma.

Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia
Published: December 08, 2022

Health following recovery from immune thrombotic thrombocytopenic purpura: the patient's perspective.

Health following recovery from immune thrombotic thrombocytopenic purpura: the patient's perspective.

Journal: Blood advances
Published: June 13, 2022

Incidence and risk factors for graft failure in the modern era of cord blood transplantation.

Incidence and risk factors for graft failure in the modern era of cord blood transplantation.

Journal: Vox sanguinis
Published: April 04, 2022
Showing 1-12 of 27

Last Updated: 09/26/2026